Christine Matthews - Jun 6, 2022 Form 4 Insider Report for Zosano Pharma Corp (ZSAN)

Role
Chief Financial Officer
Signature
/s/ Christine Matthews
Stock symbol
ZSAN
Transactions as of
Jun 6, 2022
Transactions value $
-$58
Form type
4
Date filed
6/7/2022, 07:39 PM
Previous filing
Apr 1, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ZSAN Common Stock Sale -$58 -82 -1.92% $0.71* 4.18K Jun 6, 2022 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares were sold solely to satisfy tax or other government withholding obligations in connection with the vesting of shares subject to restricted stock units of the Issuer.
F2 Reflects a 1-for-35 reverse stock split of the Issuer's common stock, effected on April 11, 2022.